Wir sind ein junges Medizintechnikunternehmen in Berlin. Wir entwickeln ein aktives Implantat, welches durch Mikrostrom Herzinsuffizienz Patienten helfen soll.
Ostern ist das Fest der Hoffnung. Hoffnung auf ein neues Leben. Wir wünschen allen Menschen zu Ostern neue Hoffnung und neue Kraft für ein besseres Morgen.
Results of our first-in-human study in short: Patients’ mean 6-minute walking distance almost doubled in 14 days and all of the patients' hearts, which were typically enlarged, had shrunk. All patients saw NYHA classification drop by two classes.
#HeartFailure#Cardiology
Results of our first-in-human study in short: Patients’ mean 6-minute walking distance almost doubled in 14 days and all of the patients' hearts, which were typically enlarged, had shrunk. All patients saw NYHA classification drop by two classes.
#HeartFailure#Cardiology
@BerlinHeals innovative implantable C-MIC device delivers encouraging clinical results in the treatment of heart failure. SCIRENT conducted the first-in-human pilot study for this device. We are proud to support Berlin Heals in this trial.
Learn more: https://t.co/RIB63ZRLl4
Results of our first-in-human study in short: Patients’ mean 6-minute walking distance almost doubled in 14 days and all of the patients' hearts, which were typically enlarged, had shrunk. All patients saw NYHA classification drop by two classes.
#HeartFailure#Cardiology
BERLIN HEALS Receives Breakthrough Device Designation from FDA for its C-MIC Heart Failure Device and Initiates Early Feasibility Study in the United States Johannes Mueller, MD @BerlinHeals#HeartFailure#Cardiology#Heart#research
https://t.co/F3djT9lX9O...
Results of our first-in-human study in short: Patients’ mean 6-minute walking distance almost doubled in 14 days and all of the patients' hearts, which were typically enlarged, had shrunk. All patients saw NYHA classification drop by two classes.
#HeartFailure#Cardiology
Results of our first-in-human study in short: Patients’ mean 6-minute walking distance almost doubled in 14 days and all of the patients' hearts, which were typically enlarged, had shrunk. All patients saw NYHA classification drop by two classes.
#HeartFailure#Cardiology
Berlin Heals has developed a completely new type of implantable medical device with the goal of treating heart failure with electrical micro current. The aim is to achieve true myocardial recovery.
#CMIC#heart#microcurrent